Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
S.B. Pharma Group provides end-to-end pharmaceutical solutions including distribution of raw materials/APIs, development/manufacturing/registration of finished dosage forms (FDF), drug-device combinations, and medical devices. Their FDF portfolio includes over 1800+ products in 10 dosage forms across various therapeutic categories with a focus on both prescription drugs (Rx) and OTC medicines[4].
They hold ISO 9001 certification for quality management systems and comply with Good Distribution Practice guidelines; they are registered in the EUDRA database with pharmaceutical wholesaler authorization under German law[4].
Their business model emphasizes flexibility to local requirements worldwide.
Clinical results not applicable—company focuses on product development/commercialization rather than clinical-stage innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SBB.